someone explain glucagon to me like I have not read a paper in years
I have had 23 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 38 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 97.9% against a claimed 98.0%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
Flair changed to match the content. Read the sidebar before posting next time and we are square.
the weight curves are unusually steep, which makes predicting individual response harder
research use only, handling and analysis, not protocols
the glucagon component changes the side effect profile, not just the efficacy
the weight curves are unusually steep, which makes predicting individual response harder
Strongly agree. Heart rate escalation needs the actual data, not impressions.
Sceptical. If this were true we would see it reflected in the data and we do not.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
That is net peptide content, not purity. Different number, different meaning.
the glucagon component changes the side effect profile, not just the efficacy
This is correct. Triple agonism is genuinely different.
the 1.7mg arm is different from 1.0mg, results do not transfer
the dosing is steep, the early fullness reports are real, and nobody knows the human safety yet
Small correction: the trial was 16 weeks, not 39. Does not change your point but people will quote it.
Slight fix: the number was 99.1, not 99.0. Decimal point, but a fairly consequential one.
The glucagon component does different things than dual agonism. The reflux are not just amplified versions.
the weight curves are unusually steep, which makes predicting individual response harder
nobody should be giving this to anyone without extensive monitoring
Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.
Crossposting this to c/glp1uk because the people who need it are not reading this community.
- 1the weight curves are unusually steep, which makes predicting individual…7 comments in this branch · started by u/hugo_pires
- 2This is correct. Triple agonism is genuinely different.5 comments in this branch · started by u/marta_vanhecke